Jayson M. Rieger, Charlottesville US
Jayson M. Rieger, Charlottesville, VA US
Patent application number | Description | Published |
---|---|---|
20080200456 | Substituted 8-Heteroaryl Xanthines - The present invention provides compounds and pharmaceutical compositions that are selective antagonists of A | 08-21-2008 |
20080262001 | AGONISTS OF A2A ADENOSINE RECEPTORS FOR TREATING RECURRENT TUMOR GROWTH IN THE LIVER FOLLOWING RESECTION - The present invention relates to a method for treating recurrent tumor metastases following liver resection that includes administration of an effective amount of an agonist of A | 10-23-2008 |
20090118309 | Selective antagonists of A2A adenosine receptors - The present invention provides compounds of formulae Ia and Ib: | 05-07-2009 |
20090162282 | SUBSTITUTED 4--PIPERIDINE-1-CARBOXYLIC ACID ESTERS AS A2AR AGONISTS - The present invention provides substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters and pharmaceutical compositions containing the same that are selective agonists of A | 06-25-2009 |
20090162292 | SUBSTITUTED 4--PIPERIDINE-1-CARBOXYLIC ACID ESTERS AS A2AR AGONISTS - The present invention provides substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters and pharmaceutical compositions containing the same that are selective agonists of A | 06-25-2009 |
20090170803 | ADJUNCTIVE TREATMENT OF BIOLOGICAL DISEASES - The present invention provides a therapeutic method for treating biological diseases that includes the administration of an effective amount of a suitable antibiotic agent, antifungal agent or antiviral agent in conjunction with an A | 07-02-2009 |
20090253647 | 2-PROPYNYL ADENOSINE ANALOGS WITH MODIFIED 5'-RIBOSE GROUPS HAVING A2A AGONIST ACTIVITY - The invention provides compounds having the following general formula (I): | 10-08-2009 |
20090280059 | SUBSTITUTED ARYL PIPERIDINYLALKYNYLADENOSINES AS A2AR AGONISTS | 11-12-2009 |
20090298788 | 2-POLYCYCLIC PROPYNYL ADENOSINE ANALOGS HAVING A2A AGONIST ACTIVITY - The invention provides compounds having the following general formula (I): | 12-03-2009 |
20100004445 | METHODS FOR THE SYNTHESIS OF UNSYMMETRICAL CYCLOALKYL SUBSTITUTED XANTHINES - The present invention provides compounds and pharmaceutical compositions that are selective antagonists of A | 01-07-2010 |
20100093770 | THERAPEUTIC AGENT FOR GLAUCOMA CONTAINING ADENOSINE DERIVATIVE AS ACTIVE INGREDIENT - A method for treating glaucoma or ocular hypertension comprising administering to a patient a pharmacologically effective amount of a compound represented by the following (1) or a salt thereof: | 04-15-2010 |
20100120765 | PYRAZOLYL SUBSTITUTED XANTHINES - The present invention provides compounds and pharmaceutical compositions that are selective antagonists of A | 05-13-2010 |
20100152127 | 2-PROPYNYL ADENOSINE ANALOGS HAVING A2A AGONIST ACTIVITY AND COMPOSITIONS THEREOF - The invention provides compounds having the following general formula (I): | 06-17-2010 |
20100166698 | NEW COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATION - The present invention describes combinations of A | 07-01-2010 |
20100273780 | SUBSTITUTED 8-HETEROARYL XANTHINES - The present invention provides compounds and pharmaceutical compositions that are selective antagonists of A | 10-28-2010 |
20110003766 | ALKOXY-CARBONYL-AMINO-ALKYNYL-ADENOSINE COMPOUNDS AND DERIVATIVES THEREOF AS A2AR AGONISTS - Provided herein are alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof and pharmaceutical compositions containing the same that are selective agonists of A | 01-06-2011 |
20110091385 | SUBSTITUTED ARYL PIPERIDINYLALKYNYLADENOSINES AS A2AR AGONISTS | 04-21-2011 |
20110136755 | 2-PROPYNYL ADENOSINE ANALOGS WITH MODIFIED 5'-RIBOSE GROUPS HAVING A2A AGONIST ACTIVITY - The invention provides compounds having the following general formula (I): | 06-09-2011 |
20110166094 | AGONISTS OF A2A ADENOSINE RECEPTORS FOR TREATING RECURRENT TUMOR GROWTH - The present invention relates to a method for treating recurrent tumor metastases following liver resection that includes administration of an effective amount of an agonist of A | 07-07-2011 |
20120035192 | SELECTIVE ANTAGONISTS OF A2A ADENOSINE RECEPTORS - The present invention provides compounds of formulae Ia and Ib: | 02-09-2012 |
20120226040 | METHODS FOR THE SYNTHESIS OF UNSYMMETRICAL CYCLOAKYL SUBSTITUTED XANTHINES - The present invention provides compounds and pharmaceutical compositions that are selective antagonists of A | 09-06-2012 |
20120309774 | SELECTIVE ANTAGONISTS OF A2A ADENOSINE RECEPTORS - The present invention provides compounds of formulae Ia and Ib: | 12-06-2012 |
20130109646 | METHOD FOR TREATING GLAUCOMA OR OCULAR HYPERTENSION WITH AN ADENOSINE DERIVATIVE | 05-02-2013 |
20130123208 | METHOD OF TREATING MULTIPLE SCLEROSIS WITH ADENOSINE RECEPTOR AGONISTS - The present invention includes a composition comprising an A | 05-16-2013 |
20140213541 | AGONISTS OF A2A ADENOSINE RECEPTORS FOR TREATING RECURRENT TUMOR GROWTH - The present invention relates to a method for treating recurrent tumor metastases following liver resection that includes administration of an effective amount of an agonist of A | 07-31-2014 |